The Valve Wire sealThe Valve Wire
July 15, 2026E. Nolan Beckett, MD · Editor
LIVE · 06:17 ET · JUL 15, 2026
EW · MDT · ABT · BSX ·
Surgical vs TranscatheterTuesday, July 14, 2026

Seven-year study finds non-surgical valve replacement holds up as well as open-heart surgery - Medical Xpress

1 min read·By E. Nolan Beckett, MD·Source: Medical Xpress
From The Valve Wire

Popular media surfaced a seven-year TAVR-vs-SAVR narrative claiming transcatheter equivalence on durability.

The underlying data (unspecified in the coverage) sits within the same evidentiary frame flagged in recent JACC editorials on "indication creep" : intermediate-risk trials pooled with low-risk trials generate composite hazard reductions that don't survive when stratified.

Meta-analyses have shown a mortality signal favoring TAVR at 5 years in lower-risk patients (HR 0.80), but the signal disappears when intermediate-risk cohorts are excluded — and no RCT has reported durable ≥10-year TAVR outcomes in patients Turkish single-center retrospective comparing robot-assisted vs transcatheter ASD closure (N=635) found longer procedural times but lower post-procedural TR with robotic surgery (3.2% device migration in transcatheter arm) — a reminder that shunt closure and valve replacement live on different risk curves.

Editor’s take pending for this article; this is the section commentary excerpt.
Source Abstract

Seven-year study finds non-surgical valve replacement holds up as well as open-heart surgery Medical Xpress

Read the Original
Full article at Medical Xpress
Open at Medical Xpress
The Valve Wire summarizes; we link out to primary sources for verification.
More in Surgical vs Transcatheter
Elsewhere in Today’s Issue